Abstract
Many substances are used in the production of biomaterials: metals (titanium), ceramics (alumina), synthetic polymers (polyurethanes, silicones, polyglycolic acid (PGA), polylactic acid (PLA), copolymers of lactic and glycolic acids (PLGA), polyanhydrides, polyorthoesters) and natural polymers (chitosan, glycosaminoglycans, collagen). With the rapid development in tissue engineering, these different biomaterials have been used as three-dimensional scaffolds and cell transplant devices. The principal biochemical and biological characteristics of the collagen-based biomaterials are presented, including their interactions with cells (fibroblasts), distinct from those of synthetic polymers, and their potential use in gene therapy through the formation of neo-organs or organoids.
Similar content being viewed by others
References
Allen, T. D., andSchor, S. L. (1983): ‘The contraction of collagen matrices by dermal fibroblasts’,J. Ultrast. Res.,83, pp. 205–219
Anselme, K., Petite, H., andHerbage, D. (1992). ‘Inhibition of calcification in vivo by acyl cross-linking of a collagen-glycosaminoglycan sponge’,Matrix,12, pp. 364
Bell, E. (1995): ‘Deterministic models for tissue engineering’,Cell. Eng.,1, pp 28–34
Bell, E., Ivarsson, B., andMerrill, C. (1979): ‘Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potentialin vitro’,Proc. Natl. Acad. Sci.,76, pp. 1274–1278
Benghuzzi, H. (1996). ‘Cytological evaluation of capsular tissue surrounding TCPL implant in adult rats’,Biomed. Sci. Instrum.,32, pp. 81–86
Berthod, F., Hayek, D., Damour, O., andCollombel, C. (1993): ‘Collagen synthesis by fibroblasts cultured within a collagen sponge’,Biomaterials,14, pp. 749–754
Bonnassar, L., andVacanti, Ch. (1998): ‘Tissue engineering: The first decade and beyond’,J. Cell. Biochem.,30/31, pp. 297–303
Boyce, S. T., Christianson, D. J., andHansbrough J.F. (1988): ‘Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes’,J. Biomed. Mater: Res.,22, pp. 939–957
Cao, X., Wang, J., Zhang, W., Chen, G., Kong, X., andTani, K. (1995): ‘Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon alpha gene therapy in combination with adoptive chemoimmunotherapy’,J. Cancer Res. Clin. Oncol.,121, pp. 457–462
Chevallay, B., Abdul-Malak, N., andHerbage, D. (2000): ‘Mouse fibroblasts in long-term culture within collagen three-dimensional scaffolds: Influence of cross-linking with diphenylphosphorylazide on matrix reorganization, growth, biosynthetic and proteolytic activities’,J. Biomed. Mater: Res.,49, pp. 448–459
Cohen-Haguenauer, O. (1996). ‘Quelle technologie pour quelle pathologie?’,Biofutur. 162, pp. 11–17.
Chen, B. F., Chang, W. C., Chen, S. T., Chen, D. S. andHwang, L. H. (1995). ‘Long-term expression of the biologically active growth hormone in genetically modified fibroblasts after implantation into a hypopysectomized rat’,Hum. Gene Ther.,6, pp. 917–926
Colombo, M. P., Ferrari, G., Stoppacciaro, A., Parenza, M., Rodolfo, M., Mavilio, F., andParmiani, G. (1991). ‘Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinomain vivo’,J. Exp. Med.,173 pp. 889–897
Cooperman, L., andMichaeli, D. (1984). ‘The immunogenicity of injectable collagen I. A 1-year prospective study’,J. Am. Acad. Dermatol.,10, pp. 638–646
Cote, M. F., Sirois, E., andDoillon, C. J. (1992): ‘In vitro contraction rate of collagen in sponge-shape matrices’,J. Biomat. Sci. Polymer Edn.,3, pp. 301–313
Danos, O., Moullier, P., andHeard, J. M. (1993): ‘Reimplantation de cellules genetiquement modifiees dans des neo-organes vascularises’,Medecine/Science,9, pp. 208–210
Demetriou, A. A., Whiting, J. F., Feldman, D., Levenson, S. M., Chowdhury, N. R., Moscioni, A. D., Kram, M., andChowdhury, J. R. (1986): ‘Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes’,Science,233, pp. 1190–1192
Doillon, C. J., Whyne, C. F., Brandwein, S., andSilver, F. H. (1986): ‘Collagen-based wound dressings: control of the pore structure and morphology’,J. Biomed. Mater. Res.,20, pp. 1219–1228
Doillon, C. J. (1988). ‘Porous collagen sponge wound dressings:in vivo andin vitro studies’,J. Biomat. Applic.,2, pp. 562–577
Dwarki, V. J., Belloni, P., Nijar, T., Smith, J., Couto, L., andRabier, M. et al. (1995). ‘Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice’,Proc. Natl. Acad. Sci. USA,92, pp. 1023–1027
Eckes, B., Mauch, C., Hÿppe, G., andKrieg, T. (1993): ‘Downregulation of collagen synthesis in fibroblasts within three-dimensional collagen lattices involves transcriptional and posttranscriptional mechanisms’,FEBS Lett.,318, pp. 129–133
Ehrlich, H. P. (1988): ‘The modulation of contraction of fibroblast populated collagen lattices by types I, II and III collagen’,Tiss. Cell,20, pp. 47–50
Ehrlich, H. P., Buttle, D. J., andBernanke, D. H. (1989): ‘Physiological variables affecting collagen lattice contraction by human dermal fibroblasts’,Exp. Mol. Pathol.,50, pp. 220–229
Ehrlich, H. P., Rockwell, W. B., Cornwell, T. L., andRajaratnam, B. M. (1991). ‘Demonstration of a direct role for myosin light chain kinase in fibroblast-populated collagen lattice contraction’J. Cell. Physiol.,146, pp. 1–7
Ehrmann, R. L. andGey, G. O. (1956): ‘The growth of cells on a transparent gel of reconstituted rat tail collagen’,J. Natl. Acad. Sci.,16, pp. 1375
Ellingsworth, L. R., DeLustro, F., Brennan, J. E., Saamura, S., andMcPherson, J. (1986). ‘The human response to reconstituted bovine collagen’,J. Immunol.,136, pp. 877–882
Gabrilovich, D. I., Cunningham, H. T., andCarbone, D. P. (1996): ‘IL-12 and mutant P53 peptide-pulsed dendritic cells for specific immunotherapy of cancer’,J. Immunother: Emphasis Tumor Immuno.,19, pp. 414–418
Gillery, P., Serpier, H., Polette, M., Bellon, G., Glaver, C., Wegrowski, Y., Birembaut, P., Kalis, B., Cariou, R., andMaquart, F.X. (1992). ‘Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts’,Eur. J. Cell. Biol.,57, pp. 244–253
Guidry, C., andGrinnell, F. (1987): ‘Heparin modulates the organization of hydrated collagen gels and inhibits gel contraction by fibroblasts’,J. Cell Biol.,104, pp. 1097–1103
Gullberg, D., Tingstrom, A., Thuresson, A. C., Olsson, L., Tetracio, L., Borg, T. K., andRubin, K. (1990): ‘Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF’,Exp. Cell Res.,186, pp. 264–272
Ho-Sung, L., Tsuchihashi, M., Tenshin, S. andKawata T. (1994): ‘Effect of retinoic acid on contraction of collagen gel induced by fibroblasts’,Biochem. Biophys. Res. Com.,205, pp. 455–459
Huc, A. (1993): ‘Les biomateriaux a base de collagene’,Lyon Pharmaceutique,44, pp. 309–319
Imamura, E., Sawatani, O., Koyanagi, H., Noishiki, Y., andMiyata, T. (1989): ‘Epoxy compounds as a new cross-linking agent for porcine aortic leaflets: subcutaneous implant studies in rats’,J. Card. Surg.,4, pp. 50–57
Kahn, A. (1992): ‘Therapie genique’,Med. Sci. 8, pp. 3–33
Khor, E. (1997): ‘Methods for treatment of collagenous tissues for bioprosthesis’,Biomaterials,18, pp. 95–105
Klein, C. E., Dressel, D., Steinmayerauch, C., Eckes, B., Krieg, T., Bankert, R. B., andWeber, L. (1991): ‘Integrinα 2β1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils’,J. Cell Biol.,115, pp. 1427–1436
Kleinmann, H. K., Rohrbach, D. H., Terranova, V. P., et al. (1982). ‘Collagenous matrices as determinants of cell function’ inFurthmayr, H. (Ed.). ‘Immunochemistry of the extracellular matrix, vol. 2’ (CRC Press, Boca Raton) pp. 151–174
Klopper, P. J. (1986): ‘Collagen in surgical research’,Eur. Surg. Res.,18, pp. 218–223
Lambert, C. A., Soudant, E. P., Nusgens, B. V., andLapiere, C. M. (1992): ‘Pretranscriptional regulation of extracellular matrix macromolecules and collagenase expression in fibroblasts by mechanical forces’,Lab. Invest.,66, pp. 444–451
Langer, R., andVacanti, J. P. (1993): ‘Tissue engineering’,Science,260, pp. 920–926
Langholz, O., Reckel, D., Mauch, C., Kozlowska, E., Bank, I., Krieg, T., andEckes, B. (1995): ‘Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated byα 2β1 andα 2β1 integrins’,J. Cell Biol.,131, pp. 1903–1915
Levy, R. J., Schoen, F. J., Sherman, F. S., Nichols, J., Hawley, M. A., andLund, S. A. (1986). ‘Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments’,Am. J. Pathol.,122, pp. 71–82
McCoy, J. P., Schade, W. J., Siegle, R. J., Waldinger, T. P., Vanderveen, E. E., andSwanson, N. A. (1985). ‘Characterization of the humoral immune response to bovine collagen implants’,Arch. Dermatol.,121, pp. 990–994
McPherson, J. M. (1992): ‘The utility of collagen-based vehicles in delivery of growth factors for hard and soft tissue wound repair’,Clin. Mater.,9, pp. 225–234
Mauch, C., Hatamochi, A., Scharffetter, K., andKrieg, T. (1988). ‘Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel’,Exp. Cell Res.,178 pp. 493–503
Mauch, C., Adelmann-Grill, B., Hatamochi, A., andKrieg, T. (1989): ‘Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen’,FEBS Lett.,250, pp. 301–305
Middelkoop, E., De Vries, H. J. C., Ruuls, L., Everts, V., Wildevuur, C.H.R., andWesterhof, W. (1995). ‘Adherence, proliferation and collagen turnover by human fibroblasts seeded into different types of collagen sponges’,Cell Tissue Res.,280, pp. 447–453
Miyata, T., Taria, T., andNoishiki, Y. (1992): ‘Collagen engineering for biomaterial use’,Clin. Mater.,9, pp. 139–148
Montesano, R., andOrci, L. (1988): ‘Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing’,Proc. Natl. Acad. Sci. USA,85, pp. 4894–4897
Moullier, P., Marechal, V., Danos, O., andHeard, J. M. (1993): ‘Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts’Transplantation,56, pp. 427–432
Naffakh, N., Henri, A., Villeval, J. L., Rouyer-Fessard, P., Moullier, P., Blumenfeld, N., Danos, O., Vainchenker, W., Heard, J. M., andBeuzard, Y. (1995). ‘Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts’,Proc. Natl. Acad. Sci. USA,92, pp. 3194–3198
Nakagawa, S., Pawelek, P., andGrinnell, F. (1989a): ‘Longterm culture of fibroblasts in contracted collagen gels: effect on cell growth and biosynthetic activity’,J. Invest. Dermatol. 93, pp. 792–798
Nakagawa, S., Pawelek, P., andGrinnell, F. (1989b): ‘Extracellular matrix organization modulates fibroblast growth and growth factor responsiveness’,Exp. Cell Res.,182, pp. 572–582
Nimni, M.E. (1997): ‘Polypeptide growth factors: targeted delivery system’,Biomaterials,18, pp. 1201–1225
Nishiyama, T., Tsunenaga, M., Nakayama, Y., Adachi, E., andHayashi, T. (1989): ‘Growth rate of human fibroblasts is repressed by the culture within reconstituted collagen matrix but not by the culture on the matrix’,Matrix,9, pp. 193–199
Nusgens, B., Merrill, C., Lapiere, C., andBell, E. (1984): ‘Collagen biosynthesis by cells in a tissue equivalent matrix in vitro’,Collagen Rel. Res.,4, pp. 351–364
O'Brien, T. K., Gabbay, S., Parkes, A. C., Knight, R. A., andZalesky, P. J. (1984): ‘Immunological reactivity to a new glutaradehyde tanned bovine pericardial heart valve’,Trans. Am. Soc. Artif. Intern. Organs,3, pp. 440–444
Olde Damink, L. H. H. (1996): ‘Cross-linking of dermal sheep collagen using a water-soluble carbodiimide’,Biomaterials,17, pp. 765–773
Pachence, J. M., Berg, R. A., andSilver, F. H. (1987): ‘Collagen: its place in the medical device industry’,MD&DI,1, pp. 49–55
Peterson, M. J., Kaplan, J., Jorgensen, C. M., Schmidt, L. A., Li L., andMorgan, J. R. et al. (1995): ‘Sustained production of human transferrin by transduced fibroblasts implanted into athymic mice: a model for somatic gene therapy’,J. Invest. Dermatol.,104, pp. 171–176
Pette, H., Rault, I., Huc, A., Menasche, P., andHerbage, D. (1990). ‘Use of the acyl azide method for cross-linking collagen-rich tissues such as pericardium’,J. Biomed. Mater. Res.,24, pp. 179–187
Petite, H., Frei, V., Huc, A., andHerbage, D. (1994): ‘Use of diphenylphosphorylazide for cross-linking collagen-based biomaterials’,J. Biomed. Mater: Res.,28, pp. 159–165
Postlethwaite, A. E., Seyer, J. M., andKang, A. H. (1978): ‘Chemotactic attraction of human fibroblasts by type I, II and III collagens and collagen-derived peptides”,Proc. Natl. Acad. Sci. USA,75, pp. 871–875
Ramshaw, J. A. M., Werkmeister, J. A., andGlattauer, V. (1995): ‘Collagen-based biomaterials’,Biotechnol. Genet. Eng. Rev.,13, pp. 335–382
Rault, I., Frei, V., Herbage, D., Abdul-Malak, N., andHuc, A. (1996): ‘Evaluation of different chemical methods for cross-linking collagen gel, films and sponges’,J. Mater. Sci. Mater. Med.,7, pp. 215–221
Riikonen, T., Westermarck, J., Koivisto, L., Broberg, A., Kŝhŝri, V. M., andHeino, J. (1995). ‘Integrinα 2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression’,J. Biol. Chem.,270, pp. 13548–13552
Rosenthal, F. M., andKohler, G. (1997): ‘Collagen as matrix for neo-organ formation by gene-transfected fibroblasts’,Anticancer Res.,17, pp. 1179–1186
Schiro, J. A., Chan, B. M. C., Roswit, W. T., Kassner, P. D., Pentland, A. P., Hemter, M. E., Eisen, A. Z., andKupper, T. S. (1991). ‘Integrinα 2β1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells,Cell,67, pp. 403–410
Seltzer, J. L., Lee, A. Y., Akers, K. T., Sudbeck, B., Southon, E. A., Wayner, E. A., andEisen, A. Z. (1994): ‘Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction’,Exp. Cell Res. 213, pp. 365–374
Suminami, Y., Elder, E. M., Lotze, M. T., andWhiteside, T. L. (1995): ‘In situ interleukin-4 gene expression in cancer patients treated with genetically modified tumor vaccine. Cancer’,J. Immunother: Emphasis Tumor Immuno.,17, pp. 238–248
Tahara, H., Zitvoge, L., Storkus, W. J., Robbin, P. D., andLotze, M. T. (1996): ‘Murine models of cancer cytokine gene therapy using interleukine-12’,Ann. N Y Acad. Sci.,795, pp. 275–283
Thompson, J. A., Haudenschild, C. C., Anderson, K. D., DiPietro, J. M., Anderson, W. F., andMaciag, T. (1989). ‘Heparin-binding growth factor 1 induces the formation of organoid neovascular structuresin vivo’,Proc. Natl. Acad. Sci. USA,86, pp. 7928–7932
Timpl, R., andMartin, G. R. (1981): ‘Components of basement membranes’ inFurthmayr, H. (Ed.): ‘Immunochemistry of the extracellular matrix, vol. 2’ (CRC Press, Boca Raton), pp. 119–150
Tiollier, J., Dumas, H., Tardy, M., andTayot, J. L. (1990): ‘Fibroblast behaviour on gels of type I, III and IV human placental collagens’,Exp. Cell Res.,191, pp. 95–104
Tomasek, J. J., andAkiyama, S. K. (1992): ‘Fibroblast-mediated collagen gel contraction does not require fibronectin-alpha 5 beta 1 integrin interaction’,Anat. Rec.,234, pp. 153–160
Tomasek, J. J., Halliday, N. L., Updike, D. L., Ahern-Moore, J. S., Vu, T. K. H., Liu, R. W., andHoward, E. W. (1997): ‘Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton’,J. Biol. Chem.,272, pp. 7482–7487
Tuckwell, D.S., andHumphries, M. J. (1993) ‘Molecular and cellular biology of integrins’,Crit. Rev. Oncol. Hematol.,15, pp. 149–171
Unemori, E. N., andWerb, Z. (1986): ‘Reorganization of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels’,J. Cell Biol.,103, pp. 1021–1031
Weadock, K., Olsen, R. M., andSilver, R. H. (1984): ‘Evaluation of collagen crosslinking techniques’,Biomater. Med. Dev. Artif. Org.,11, pp. 294–318
Werkmeister, J. A., andRamshaw, J. A. M. (1992): ‘Editorial: collagen-based biomaterials’,Clin. Mater.,9, pp. 137–138
Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W., Ahmed-Ansari, A., Sell, K. M., Pollard, J. W., andStanley E. R. (1990): ‘Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse’,Proc. Natl. Acad. Sci. USA 87, pp. 4828–4832
Xu, J. andClark, R. A. F. (1997): ‘A three-dimensional collagen lattice induces protein kinase C-ξ activity: role in α2 integrin and collagenase mRNA expression’,J. Cell Biol.,136, pp. 473–483
Yamato, M., Yamamoto, K., andHayashi, T. (1993): ‘Age-related changes in collagen gel contraction by cultured human lung fibroblasts resulting in cross-over of contraction curves between young and aged cells’,Mech. Ageing Dev.,67, pp. 149–158
Yamato, M., Adachi, E., Yamamoto, K., andHayashi, T. (1995): ‘Condensation of collagen fibrils to the direct vicinity of fibroblasts as a cause of gel contraction’,J. Biochem.,117, pp. 940–946
Yannas, I. V., Burke, J. F., Orgill, D. P., andSkrabut, E. M. (1982): ‘Wound tissue can utilize a polymeric template to synthesise a functional extension of skin’,Science,215, pp. 174–176
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chevallay, B., Herbage, D. Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med. Biol. Eng. Comput. 38, 211–218 (2000). https://doi.org/10.1007/BF02344779
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02344779